Advanced Renal Technologies

Advanced Renal Technologies is a medical technology company specializing in the development of innovative dialysis solutions for patients with end-stage renal disease. The company's flagship product, Citrasate, is a citric acid-based acid concentrate used during hemodialysis to improve treatment efficiency and patient outcomes. By replacing traditional acetic acid with citric acid, the technology provides local anticoagulation within the dialysis circuit, reducing the need for systemic heparin. This approach minimizes clotting in the extracorporeal circuit and has been shown to enhance the clearance of small molecules during treatment. Founded in 1995 and headquartered in Bellevue, Washington, the company was a pioneer in citrate-based dialysate technology before being acquired by Nipro Corporation in 2011.